Highlands Oncology Group

Highlands Oncology Group (HOG) is a premier multidisciplinary cancer care and clinical research center headquartered in Northwest Arkansas. Founded in 1996, the group operates as a comprehensive oncology practice providing medical oncology, radiation oncology, and specialized surgical services. HOG is internationally recognized for its robust clinical trials program, particularly its dedicated Phase I Clinical Trials Unit, which is among the most active community-based research sites in the United States. By partnering with major global pharmaceutical and biotechnology companies, the group provides patients with early access to cutting-edge therapeutic modalities including targeted therapies, next-generation immunotherapies, and cellular treatments. Their integrated model combines sophisticated genomic testing with community-based care, making them a vital partner in the late-stage development of high-impact oncology assets.